Health and Human Services Secretary Alex Azar said the administration's "Operation Warp Speed" is increasing the likelihood that the USA will have at least one reliable COVID-19 vaccine by the end of the year.
The company said the vaccine is producing more antibodies with generally tolerable side effects in early-stage clinical trials. "We're talking about an RNA virus and that is especially tough to make vaccines against". Johnson & Johnson has received about $456 million for clinical trials and other vaccine development activities under the Biomedical Advanced Research and Development Authority.
However, the team could not fulfill Jokowi's request, as the clinical trials for the possible vaccine entailed a string of stringent protocols that would otherwise take years to complete under normal circumstances.
"Johnson & Johnson's global team of experts has worked tirelessly alongside BARDA and scientific partners to pursue a SARS-CoV-2 vaccine that can help to stop the spread of COVID-19".
New York, Aug 6 (IANS) Global healthcare company Johnson & Johnson has reached a $1 billion deal with the United States government for manufacturing and delivery of 100 million doses of its Covid-19 vaccine that is being tested.
"We give them two shots". "These vaccine candidates are very promising and we all look forward to the day when restrictions can be lifted entirely". Following positive preclinical studies, both single and two-dose regiments of the vaccine candidate are being evaluated in a Phase 1/2a study in healthy volunteers in the US and Belgium.
The process of developing a new vaccine involves thousands of hours of research and lab testing before it can be administered to humans safely.
Moderna CEO Stephane Bancel said in a conference call Wednesday that small amounts of Moderna's vaccine have been priced between US$32 and US$37 a dose, but that the price would be lower for big orders. J&J said its goal is to supply more than 1 billion doses globally through 2021.
In addition, by leveraging Amazon Redshift - AWS's fully managed data warehousing service - Moderna's scientists and engineers aggregate results from dozens of experiments that are running in parallel and can easily query and share insights to refine their design and production cycle quickly.
He also applauded the government for getting eggs in more than one basket, because he said there could be unexpected issues that prevent a vaccine from being successful.
The race to come up with a coronavirus vaccine is fast and furious.